Profile of Depressive Symptoms in Parkinsons Disease

Completed

• Conditions: Depression; Parkinson Disease

• Registration Number: NCT00349310
• Lead Sponsor: Boehringer Ingelheim

Brief Summary

To explore or establish the relationship between cognitive, mood and motor symptoms in PD to scores on depression rating scales in a naturalistic setting.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-04-01
• Study First Submitted: 2006-07-05
• Study First Submitted QC: 2006-07-05
• Study First Posted: 2006-07-06
• Primary Completion: 2006-10-01
• Study Completion: 2006-10-01
• Status Verified: 2023-12
• Last Update Submitted: 2023-12-07
• Last Update Posted: 2023-12-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1018

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HADS, HAMD-17, BDI-1A, FAB (cognitive), DSM-IV (mood- part A, B, C, E) and UPDRS	Up to 6 months

Trial Locations

Locations (18)

Boehringer Ingelheim Investigational Site; 🇬🇧 Newark, United Kingdom

Hopital Rangueil; 🇫🇷 Toulouse cedex 9, France

Hopital Purpan; 🇫🇷 Toulouse cedex, France

Neurologisches Fachkrankenhaus fur; 🇩🇪 Beelitz-Heilstatten, Germany

Universitatsklinikum Carl Gustav Carus Dresden; 🇩🇪 Dresden, Germany

Gertrudis-Kliniken Biskirchen; 🇩🇪 Leun, Germany

Parkinson Klinik Wolfach; 🇩🇪 Wolfach, Germany

Policlinico di Catania; 🇮🇹 Catania, Italy

Azienda Ospedaliera S. Martino; 🇮🇹 Genova, Italy

Universita Federico II; 🇮🇹 Napoli, Italy

Scroll for more (8 remaining)